DK0871434T4 - Oralt farmaceutisk sammensætning med modificeret frigivelse indeholdende 5-ASA og fremgangsmåde til behandling af tarmsygdomme - Google Patents

Oralt farmaceutisk sammensætning med modificeret frigivelse indeholdende 5-ASA og fremgangsmåde til behandling af tarmsygdomme

Info

Publication number
DK0871434T4
DK0871434T4 DK96943884T DK96943884T DK0871434T4 DK 0871434 T4 DK0871434 T4 DK 0871434T4 DK 96943884 T DK96943884 T DK 96943884T DK 96943884 T DK96943884 T DK 96943884T DK 0871434 T4 DK0871434 T4 DK 0871434T4
Authority
DK
Denmark
Prior art keywords
asa
treatment
pharmaceutical composition
release pharmaceutical
composition containing
Prior art date
Application number
DK96943884T
Other languages
Danish (da)
English (en)
Other versions
DK0871434T3 (da
Inventor
Svenn Kluever Jepsen
Soren Halskov
Original Assignee
Ferring Farma Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0871434(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Farma Lab filed Critical Ferring Farma Lab
Application granted granted Critical
Publication of DK0871434T3 publication Critical patent/DK0871434T3/da
Publication of DK0871434T4 publication Critical patent/DK0871434T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96943884T 1995-12-21 1996-12-23 Oralt farmaceutisk sammensætning med modificeret frigivelse indeholdende 5-ASA og fremgangsmåde til behandling af tarmsygdomme DK0871434T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57595495A 1995-12-21 1995-12-21
PCT/DK1996/000551 WO1997023199A1 (fr) 1995-12-21 1996-12-23 Composition pharmaceutique orale a liberation modifiee contenant 5-asa et procede de traitement de maladies intestinales

Publications (2)

Publication Number Publication Date
DK0871434T3 DK0871434T3 (da) 2002-01-07
DK0871434T4 true DK0871434T4 (da) 2008-04-07

Family

ID=24302375

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96943884T DK0871434T4 (da) 1995-12-21 1996-12-23 Oralt farmaceutisk sammensætning med modificeret frigivelse indeholdende 5-ASA og fremgangsmåde til behandling af tarmsygdomme

Country Status (28)

Country Link
EP (1) EP0871434B2 (fr)
JP (1) JP4714836B2 (fr)
KR (2) KR100598714B1 (fr)
CN (1) CN1155369C (fr)
AT (1) ATE205704T1 (fr)
AU (1) AU702934B2 (fr)
BG (1) BG63484B1 (fr)
BR (1) BR9612213A (fr)
CA (1) CA2240281C (fr)
CZ (1) CZ289290B6 (fr)
DE (2) DE69615400T3 (fr)
DK (1) DK0871434T4 (fr)
EE (1) EE03740B1 (fr)
ES (1) ES2149733T5 (fr)
HK (1) HK1017615A1 (fr)
HU (1) HU228856B1 (fr)
IL (1) IL124858A (fr)
IS (1) IS1834B (fr)
NO (1) NO320498B1 (fr)
NZ (1) NZ325201A (fr)
PL (1) PL186790B1 (fr)
PT (1) PT871434E (fr)
RU (1) RU2181043C2 (fr)
SI (1) SI0871434T2 (fr)
SK (1) SK282669B6 (fr)
TR (1) TR199801158T2 (fr)
UA (1) UA67721C2 (fr)
WO (1) WO1997023199A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
PT1146862E (pt) 1999-01-29 2003-09-30 Disphar Int Bv Composicoes farmaceuticas
CA2359812C (fr) 2000-11-20 2004-02-10 The Procter & Gamble Company Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
PT1441700E (pt) * 2001-10-15 2007-10-29 Ferring Bv Método para a preparação de uma composição compreendendo ácido 5-aminosalicílico para uso em tratamento de colites ulcerosas ou da doença de crohn
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
JP2007523664A (ja) * 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
EP1547601A1 (fr) 2003-12-23 2005-06-29 Ferring B.V. Procédé de revêtement
RU2297835C1 (ru) 2005-09-26 2007-04-27 Закрытое акционерное общество "Партнер" Препарат для лечения неинфекционных воспалительных болезней кишечника
CN101538218B (zh) * 2006-04-13 2013-05-29 纽若泰克制药株式会社 用于治疗或预防退行性和炎症性疾病的药物组合物
WO2010020772A2 (fr) * 2008-08-22 2010-02-25 Reckitt Benckiser Healthcare (Uk) Limited Perfectionnements de compositions ou apparentés à des compositions
US8865688B2 (en) 2008-10-03 2014-10-21 Dr. Falk Pharma Gmbh Compositions and methods for treatment of bowel diseases with granulated mesalamine
EP2340812A1 (fr) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules pour préparations pharmaceutiques, procédés et appareil pour leur production
RU2463055C2 (ru) * 2011-01-12 2012-10-10 Петр Леонидович Щербаков Способ лечения воспалительных заболеваний кишечника
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
WO2013144176A1 (fr) 2012-03-30 2013-10-03 Laboratorios Del Dr. Esteve, S.A. Formulation à libération contrôlée comprenant de la mésalamine
RU2752082C1 (ru) * 2020-09-29 2021-07-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500432A (fr) * 1980-03-20 1982-03-11
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
KR20050087886A (ko) 2005-08-31
CN1207672A (zh) 1999-02-10
NO982904L (no) 1998-06-22
IL124858A (en) 2003-03-12
IS4772A (is) 1998-06-15
HUP0001084A2 (hu) 2000-11-28
KR19990076584A (ko) 1999-10-15
RU2181043C2 (ru) 2002-04-10
SK282669B6 (sk) 2002-11-06
SK83498A3 (en) 1999-01-11
EE9800191A (et) 1998-12-15
BG102556A (en) 1999-02-26
JPH11510191A (ja) 1999-09-07
IL124858A0 (en) 1999-01-26
EP0871434A1 (fr) 1998-10-21
HU228856B1 (en) 2013-06-28
NZ325201A (en) 1998-11-25
BG63484B1 (bg) 2002-03-29
PL327323A1 (en) 1998-12-07
CA2240281A1 (fr) 1997-07-03
IS1834B (is) 2002-11-15
HUP0001084A3 (en) 2000-12-28
TR199801158T2 (xx) 1998-09-21
HK1017615A1 (en) 1999-11-26
EP0871434B1 (fr) 2001-09-19
WO1997023199A1 (fr) 1997-07-03
CZ289290B6 (cs) 2001-12-12
BR9612213A (pt) 1999-12-28
AU1366197A (en) 1997-07-17
ES2149733T3 (es) 2002-04-01
NO982904D0 (no) 1998-06-22
UA67721C2 (en) 2004-07-15
PL186790B1 (pl) 2004-02-27
ES2149733T1 (es) 2000-11-16
DE69615400T2 (de) 2002-05-23
DE69615400T3 (de) 2008-08-07
ES2149733T5 (es) 2008-05-01
CA2240281C (fr) 2007-02-27
DE871434T1 (de) 2001-04-05
CZ194698A3 (cs) 1998-10-14
NO320498B1 (no) 2005-12-12
SI0871434T1 (en) 2002-04-30
KR100542544B1 (ko) 2006-05-10
JP4714836B2 (ja) 2011-06-29
EP0871434B2 (fr) 2007-12-12
SI0871434T2 (sl) 2008-04-30
PT871434E (pt) 2002-02-28
AU702934B2 (en) 1999-03-11
EE03740B1 (et) 2002-06-17
DE69615400D1 (de) 2001-10-25
CN1155369C (zh) 2004-06-30
KR100598714B1 (ko) 2006-07-10
ATE205704T1 (de) 2001-10-15
DK0871434T3 (da) 2002-01-07

Similar Documents

Publication Publication Date Title
DK0871434T4 (da) Oralt farmaceutisk sammensætning med modificeret frigivelse indeholdende 5-ASA og fremgangsmåde til behandling af tarmsygdomme
DK0825858T3 (da) Flerumættede omega-3-fedtsyrer til behandling af inflammatorisk tarmsygdom i kapsler med tidsafhængig frigivelse
DE69720985D1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
ATE125445T1 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
DK0797435T3 (da) Matrice til kontrolleret frigivelse af lægemidler
WO2008085484A3 (fr) Procédé de traitement de l'affection abdominale inflammatoire
ES2180683T3 (es) Preparacion de nifedipina de liberacion con duracion prolongada.
HUP0101017A2 (hu) Készítmény és eljárás szájon át adagolható vakcinák és gyógyászati hatóanyagok szisztémás bevitelére
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
DE69824748D1 (de) Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen
DE60006362D1 (de) Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
MXPA04003506A (es) Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease